Neuberger Berman Group LLC Puma Biotechnology, Inc. Transaction History

Neuberger Berman Group LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 13, 2018	SELL	$41.2 - $59.85 $206,000 - $299,250	-5,000 Closed	0 $0
Q2 2018 Aug 13, 2018	BUY	$48.3 - $68.25 $241,500 - $341,250	5,000 New	5,000 $296,000
Q1 2018 May 08, 2018	SELL	$59.7 - $99.25 $143,280 - $238,200	-2,400 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$93.85 - $132.45 $384,785 - $543,045	-4,100 Reduced 63.08%	2,400 $237,000
Q3 2017 Nov 15, 2017	BUY	$72.0 - $119.75 $468,000 - $778,375	6,500	6,500 $778,000

29.5M

842K

32.2K

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $141M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

Stay updated on Neuberger Berman Group LLC with notifications on news.